Common Contracts
1 similar Master Clinical Trial Agreement contracts
MASTER CLINICAL TRIAL AGREEMENT AMENDMENT 2 FOR RENEWALMaster Clinical Trial Agreement • August 25th, 2020
This Master Clinical Trial Agreement Amendment No. 2 (hereinafter the “AMENDMENT No. 2”) effective as of 13 August 2020, hereinafter the “Amendment Effective Date”, and is by and between UCB BIOSCIENCES, INC. with an address at 8010 Arco Corporate Drive, Raleigh, NC 27617 ("SPONSOR”) and the following member institutions of The University of Texas System, (“SYSTEM”), having a place of business at 210 West 7th Street, Austin , TX 78701, as governed by its Board of Regents (“Board”): THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON, THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO, THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON, THE UNIVERSITY OF TEXAS AT AUSTIN, THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, and THE UNIVERSITY OF TEXAS RIO GRANDE VALLEY
